COPERNICANNCT06353594
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
StatusRecruiting
PhaseNot applicable
SponsorHospital Universitario La Fe
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Sep 2026 to Mar 2028
- Eligibility criteria expanded, about 11 words
- Collaborators: 1 to 2
- Publications: details revised at 1 of 1 entry
- Notable Lead sponsor: Jorge Sanz Sanchez to Hospital Universitario La Fe
- Study sites: 15 to 23
- Collaborators expanded, about 1 word
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Target lesion failure (TLF)
Timeframe: 12 months
Secondary (9)
Incidence of all-cause death
Incidence of myocardial infarction
Incidence of cardiovascular death
Incidence of target lesion revascularization
Incidence of stent thrombosis
Show 4 moreShow less
Incidence of acute vessel closure
Incidence of stroke
Incidence of acute kidney injury
Incidence of bleeding
Arms and interventions
DCB-basedExperimental
Reduced stent PCI strategy: Culprit lesion revascularization with DCB will be performed after coronary predilation if residual stenosis ≤30%, lack of dissections \>type B and TIMI 3 flow. If the aforementioned culprit-lesion characteristics are not achieved after DCB-PCI, a DES will be implanted.
DES-basedNo intervention
Control group
Devices: Primary PCI
Sites
23 sites in 1 country